Pharmacy
News
EC approves FC fusion protein for hemophilia B
Photo courtesy of Biogen The European Commission (EC) has approved eftrenonacog alfa (Alprolix) to treat hemophilia B. This recombinant factor...
News
EC approves first immunostimulatory antibody to treat MM
Photo courtesy of Bristol-Myers Squibb The European Commission (EC) has approved elotuzumab (Empliciti) for use in combination with lenalidomide...
News
EC approves long-acting hemophilia B therapy
The European Commission (EC) has approved albutrepenonacog alfa (Idelvion) to treat and prevent bleeding in children and adults with hemophilia B...
News
Change to EHR can increase use of generic drugs
Photo courtesy of NIH Changing the default prescription settings in the electronic health record (EHR) can increase the prescribing rates of...
News
Company warns of counterfeit drug
Photo by Bill Branson Heritage Pharmaceuticals Inc., has announced the existence of a counterfeit drug product labeled as BiCNU® (carmustine for...
News
FDA grants priority review for blinatumomab
and solution for infusion Photo courtesy of Amgen The US Food and Drug Administration (FDA) has accepted for priority review the supplemental...
News
CAR T-cell therapy granted orphan designation
The US Food and Drug Administration (FDA) has granted orphan drug designation for the chimeric antigen receptor (CAR) T-cell therapy KTE-C19 as a...
News
CHMP recommends approving drug to treat FL
The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that obinutuzumab (Gazyvaro), an anti-CD20...
News
Costs for orally administered cancer drugs on the rise
Photo courtesy of the CDC New orally administered cancer drugs are much more expensive in their first year on the market than such drugs launched...
News
Product approved for hemoglobin maintenance
Image courtesy of NHLBI The US Food and Drug Administration (FDA) has approved the use of a powder formulation of ferric pyrophosphate citrate (...
News
Team designs ‘targeted EPO’
Researchers say they have used a rational design approach to create a safer variant of the drug erythropoietin (EPO). This “targeted EPO”...